At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 245 enrolled
Drug / intervention
bepotastine besilate ophthalmic solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients
In Brief
A Phase 2 clinical trial evaluating bepotastine besilate ophthalmic solution and placebo comparator ophthalmic solution for Allergic Conjunctivitis. Completed, enrolled 245 participants across 1 site.
Detailed Summary
The purpose of this study is to study the safety and efficacy of bepotastine besilate ophthalmic solution in allergic conjunctivitis patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAllergic Conjunctivitis
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2010
First PostedAug 2010
Primary CompletionOct 2010
Study CompletionDec 2010
TodayJul 2026
First PostedAug 4, 2010
Enrollment StartJun 1, 2010
Primary CompletionOct 1, 2010
Study CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.9 years ago
Interventions
bepotastine besilate ophthalmic solutiondrug
sterile ophthalmic solution
placebo comparator ophthalmic solutiondrug
sterile ophthalmic solution